Trial Listings

Trial Listings

We are currently conducting one or more trials in the below listed indications:

Child and Adolescent:

ADHD in Adolescents Ages 13-17
Depression in Children and Adolescents Ages 7-17
Adolescent Schizophrenia Ages 13- 17
Pediatric and Adolescent Bipolar Disorder Ages 10-17
GAD in Children and Adolescents Ages 7-17

Adult Studies:

Major Depressive Disorder
Major Depressive Disorder with Partial Response to Current Antidepressant
Bipolar Depression
Schizophrenia Disorder (ages 18+)

Generalized Anxiety Disorder in Children and Adolescents

Are you concerned about your child's worrying? ARG is conducting a research study to find out if an investigational medication works and if it is safe in children and teens with generalized anxiety disorder, also known as GAD. Unlike adults with generalized anxiety disorder, children and teens with anxiety disorders often don't realize that their anxiety is excessive or out of proportion for the situation. Therefore, it is important for parents to recognize the difference between "normal" worry and generalized anxiety disorder.

"Normal" worry is when your child's worries:

Do not get in the way of his/her daily activities and responsibilities.
Are able to be controlled.
Do not cause significant distress.
Are limited to a specific, small number of realistic concerns.
Last for only a short time period.

Generalized anxiety disorder (GAD) is when your child's worries:

Significantly interfere in his/her daily life, including: performance in school, extracurricular activities, or social life.
Make it hard to control the amount of time that he/she spends worrying.
Are extremely upsetting and stressful. Your child may tend to expect the worst.
Are about a broad variety of events- past, present, and future- such as past conversations or actions, upcoming events, school, family health, their own health, competence in sports or academics, and world events.

About The Children's Anxiety Research Study:

Approximately 260 children around the world will be participating in this research study.
Study participation will last up to 8 months. During that time, you and your child will visit the study doctor's office up to 14 times.
Children who participate will be randomly assigned to receive either the investigational medication or placebo for the first part of the study (approximately 10 weeks or 2.5 months). After this time, all children who participate in the study will receive the investigational medication until the study ends.

Eligibility Information:

In order to participate, your child must:

Be 7-17 years old
Be diagnosed with generalized anxiety disorder, as determined by the study doctor
Be generally healthy
Weigh at least 44 pounds
Be able to attend up to 14 clinic visits in 8 months with their parent and/or guardian

Your child cannot:

Be currently taking a research medication for a clinical trial
Be pregnant or breast-feeding
Have a previous or current diagnosis of schizophrenia or bipolar disorder.

For More Information

If your child's worrying sounds like generalized anxiety disorder, please speak with ARG, and consider our research study as an option. ARG will be able to tell you more about the study and determine if your child is eligible to participate.

Major Depressive Disorder

Announcing a medical research study for people with depression. Depression isn't just feelings of sadness- it can affect the way you see the world. Your body may feel constantly fatigued, and your mind may dwell on thoughts of worthlessness and guilt. If you are currently depressed and not taking an antidepressant, you may qualify for a medical research study to determine the effectiveness and safety of an investigational medication for Major Depressive Disorder. If you qualify, you'll receive investigational study medication, study-related medical exams, and lab tests at no charge. Financial compensation for time and travel may also be available.

Major Depressive Disorder with Partial Response

Even when you're treating your depression, it can leave you with a lot to handle. The Depression Outreach Study is evaluating an investigational drug that's intended to be taken with your current antidepressant (SSRI), to see if it helps to lessen any ongoing symptoms of depression. All eligible study participants will receive investigational study drugs, coverage for their current prescription antidepressant, and study-related care at no cost. If you're at least 18 years old, have been diagnosed with Major Depressive Disorder (MDD), and are taking a prescription antidepressant, you may be eligible to participate.

Bipolar Depression

Are you taking Bipolar Medication bust still struggling with Depression? If you're taking bipolar medication but still feel depressed, you may be able to take part in a local clinical research study. Doctors are researching effectiveness and safety of an investigational drug. Participants must be 18-65 years old and diagnosed with bipolar disorder. Health insurance is not required. The study study may be provided at no cost. Compensation available for time and travel.

Schizophrenia

Is Schizophrenia on your mind? Around 1 in every 140 people develops schizophrenia. That's why we're conducting HBDE, a clinical research study to compare an investigational medication to aripiprazole (an approved schizophrenia treatment) in people aged 18-65. Any study-related medications/procedures would be provided at no cost to you.

Schizophrenia

Schizophrenia is a chronic, severe and debilitating brain disease that affects about 1% of the population worldwide. Symptoms generally begin in late adolescence or early adulthood. People with Schizophrenia often suffer symptoms such as hearing internal voices not heard by others, or believing that other people are reading their minds, controlling their thoughts, or plotting to harm them. Schizophrenia is associated with significant lifelong deficits in interpersonal relationships, the ability to work and the ability to care for oneself.

Alliance Research Group is currently seeking participants to participate in a clinical research trial to help improve the lives of those who suffer from this disease.

Participants will be receive study medication and may also be compensated for their travel related expenses.

_____________________________________________________________________________Contact us about this trial

Last Updated on Friday, 05 August 2011 17:04